The α-cyclodextrin complex of the Moringa isothiocyanate suppresses lipopolysaccharide-induced inflammation in RAW 264.7 macrophage cells through Akt and p38 inhibition
暂无分享,去创建一个
E. Mazzon | P. Bramanti | S. Giacoppo | R. Iori | T. S. Rajan | P. Rollin
[1] E. Mazzon,et al. The Isothiocyanate Isolated from Moringa oleifera Shows Potent Anti-Inflammatory Activity in the Treatment of Murine Subacute Parkinson's Disease. , 2017, Rejuvenation research.
[2] Li Luo,et al. Agmatine Reduces Lipopolysaccharide-Mediated Oxidant Response via Activating PI3K/Akt Pathway and Up-Regulating Nrf2 and HO-1 Expression in Macrophages , 2016, PloS one.
[3] E. Mazzon,et al. Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages. , 2016, Fitoterapia.
[4] J. Rossiter,et al. Stability studies of isothiocyanates and nitriles in aqueous media , 2015 .
[5] Liang Feng,et al. Screening for anti-inflammatory components from Corydalis bungeana Turcz. based on macrophage binding combined with HPLC , 2015, BMC Complementary and Alternative Medicine.
[6] C. Olsen,et al. Taste detection of the non-volatile isothiocyanate moringin results in deterrence to glucosinolate-adapted insect larvae. , 2015, Phytochemistry.
[7] E. Mazzon,et al. An overview on neuroprotective effects of isothiocyanates for the treatment of neurodegenerative diseases. , 2015, Fitoterapia.
[8] A. Kong,et al. Dietary Glucosinolates Sulforaphane, Phenethyl Isothiocyanate, Indole-3-Carbinol/3,3′-Diindolylmethane: Antioxidative Stress/Inflammation, Nrf2, Epigenetics/Epigenomics and In Vivo Cancer Chemopreventive Efficacy , 2015, Current Pharmacology Reports.
[9] A. Karabay,et al. Methylsulfonylmethane modulates apoptosis of LPS/IFN-γ-activated RAW 264.7 macrophage-like cells by targeting p53, Bax, Bcl-2, cytochrome c and PARP proteins , 2014, Immunopharmacology and immunotoxicology.
[10] Yung-Hyun Choi,et al. Anti-inflammatory effects of cordycepin in lipopolysaccharide-stimulated RAW 264.7 macrophages through Toll-like receptor 4-mediated suppression of mitogen-activated protein kinases and NF-κB signaling pathways , 2014, Drug design, development and therapy.
[11] A. Descoteaux,et al. Macrophage Cytokines: Involvement in Immunity and Infectious Diseases , 2014, Front. Immunol..
[12] E. Mazzon,et al. Antiinflammatory activity of glucomoringin isothiocyanate in a mouse model of experimental autoimmune encephalomyelitis. , 2014, Fitoterapia.
[13] Hong Wang,et al. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases , 2014, Biomarker Research.
[14] Mark Boothby,et al. Cross Talk between the Akt and p38α Pathways in Macrophages Downstream of Toll-Like Receptor Signaling , 2013, Molecular and Cellular Biology.
[15] G. Rimbach,et al. Synthesis and Nrf2-inducing activity of the isothiocyanates iberverin, iberin and cheirolin. , 2013, Pharmacological research.
[16] B. A. Bakhotmah,et al. Molecular Mechanism Underlying Anti-Inflammatory and Anti-Allergic Activities of Phytochemicals: An Update , 2012, Molecules.
[17] A. Qandil. Prodrugs of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), More Than Meets the Eye: A Critical Review , 2012, International journal of molecular sciences.
[18] Ho-Young Choi,et al. Inhibition of lipopolysaccharide-induced nitric oxide and prostaglandin E2 production by chloroform fraction of Cudrania tricuspidata in RAW 264.7 macrophages , 2012, BMC Complementary and Alternative Medicine.
[19] Longqin Hu,et al. Small Molecule Modulators of Keap1‐Nrf2‐ARE Pathway as Potential Preventive and Therapeutic Agents , 2012, Medicinal research reviews.
[20] J. Slansky,et al. Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer. , 2012, Anticancer research.
[21] W. Park,et al. 6,6'-Bieckol, isolated from marine alga Ecklonia cava, suppressed LPS-induced nitric oxide and PGE₂ production and inflammatory cytokine expression in macrophages: the inhibition of NFκB. , 2012, International immunopharmacology.
[22] Y. Chau,et al. The lipopolysaccharide-induced pro-inflammatory response in RAW264.7 cells is attenuated by an unsaturated fatty acid–bovine serum albumin complex and enhanced by a saturated fatty acid–bovine serum albumin complex , 2011, Inflammation Research.
[23] S. Ghosh,et al. Crosstalk in NF-κB signaling pathways , 2011, Nature Immunology.
[24] M. D’Incalci,et al. The isothiocyanate produced from glucomoringin inhibits NF-kB and reduces myeloma growth in nude mice in vivo. , 2010, Biochemical pharmacology.
[25] S. Jachak,et al. Recent developments in anti‐inflammatory natural products , 2009, Medicinal research reviews.
[26] M. Tsai,et al. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity , 2008, Nature Reviews Immunology.
[27] Shizuo Akira,et al. Signaling to NF-?B by Toll-like receptors , 2007 .
[28] N. Perkins,et al. Transcriptional profiling of the LPS induced NF-κB response in macrophages , 2007, BMC Immunology.
[29] Farooq Anwar,et al. Moringa oleifera: a food plant with multiple medicinal uses , 2007, Phytotherapy research : PTR.
[30] Murugesan V. S. Rajaram,et al. Akt/Protein Kinase B Modulates Macrophage Inflammatory Response to Francisella Infection and Confers a Survival Advantage in Mice1 , 2006, The Journal of Immunology.
[31] Mark E. Davis,et al. Cyclodextrin-based pharmaceutics: past, present and future , 2004, Nature Reviews Drug Discovery.
[32] E. Pålsson-McDermott,et al. Signal transduction by the lipopolysaccharide receptor, Toll‐like receptor‐4 , 2004, Immunology.
[33] E. El-Omar,et al. Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[34] Sang Hyun Kim,et al. Selenium Attenuates Lipopolysaccharide-Induced Oxidative Stress Responses Through Modulation of p38 MAPK and NF-κB Signaling Pathways , 2004, Experimental biology and medicine.
[35] L. Lind. Circulating markers of inflammation and atherosclerosis. , 2003, Atherosclerosis.
[36] R. Cole,et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[37] A. Ottani,et al. Dual acting anti-inflammatory drugs: a reappraisal. , 2001, Pharmacological research.
[38] E. Chan,et al. IFN-γ + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38 mapk in a mouse macrophage cell line , 2001 .
[39] S. Makarov. NF-κB as a therapeutic target in chronic inflammation: recent advances , 2000 .
[40] L. Pfeffer,et al. NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase , 1999, Nature.
[41] Frank McCormick,et al. Akt activation by growth factors is a multiple-step process: the role of the PH domain , 1998, Oncogene.
[42] F. McCormick,et al. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. , 1997, Science.
[43] A. Toker,et al. Signalling through the lipid products of phosphoinositide-3-OH kinase , 1997, Nature.
[44] D. Hume,et al. Endotoxin signal transduction in macrophages , 1996, Journal of leukocyte biology.
[45] J. Albina,et al. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. , 1993, Journal of immunology.
[46] E. Mazzon,et al. 4(α-l-rhamnosyloxy)-benzyl isothiocyanate, a bioactive phytochemical that attenuates secondary damage in an experimental model of spinal cord injury. , 2015, Bioorganic & medicinal chemistry.
[47] J. Cho,et al. Functional role of Akt in macrophage-mediated innate immunity. , 2011, Frontiers in bioscience.
[48] E. Chan,et al. IFN-gamma + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line. , 2001, American journal of physiology. Cell physiology.
[49] P. Tak,et al. NF-kappaB: a key role in inflammatory diseases. , 2001, The Journal of clinical investigation.
[50] P. Tak,et al. NF-κB: a key role in inflammatory diseases , 2001 .
[51] S. Makarov. NF-kappaB as a therapeutic target in chronic inflammation: recent advances. , 2000, Molecular medicine today.
[52] L. Manici,et al. Cyclodextrin Assistance in the Enzymatic Degradation of the moringa Glucosinolate , 1999 .